Using silver nanoparticles, researchers create cream that avoids the transmition of HIV

Silver nanoparticles.

After discovering that silver nanoparticles are capable of blocking the entry of Human Immunodeficiency Virus (HIV) into the organism, a group of researchers from the University of Texas, in collaboration with Humberto Lara Villegas, specialist in nanoparticles and virology from the University of Monterrey, Mexico (UDEM), created a vaginal cream to control the transmition of the virus.

Lara Villegas explains that HIV makes its entry to (CD4) of the organism with the aid of a protein known as GP120, which allows the virus adherence to the cells. This same principle is used by to attach themselves to this protein and block it, turning the virus inactive.

The Mexican researcher says that the cream has been tested in samples of human tissue and has proven the efficiency of silver nanoparticles to avoid the transmition of the virus through cervical mucous membrane.

The researcher from UDEM, who has worked in Israel and The United States, says that after applied, the cream starts to work in less than a minute, and has an effective protection of up to 72 hours.

Given that the function of this product is the inactivation of the virus, although this is a vaginal cream, will also protect the sexual partner.

"Normally, the medication used against the virus acts within the cell to prevent its replication. This is a very different case, given that the nanoparticle goes directly against the HIV and no longer allows its entry to the cell."

Silver nanoparticles.

So far, no toxicity of the silver nanoparticles has been reported, although he adds that research has yet to be performed to evaluate the possible side effects of silver properties. "Right now, I am certain that this microbicide is going to prevent the virus entering the organism, but I cannot yet assure that is totally harmless, because the clinical trials are a long and expensive process," he says.

He adds that the use of gels is usually accompanied by irritation, which favors the entry of the , which is why the cream was enriched with an anti-inflammatory.

Next, with the obtained results, researchers will perform experimentation in mice that accept human cells, with human later.

He says that this cream could prevent the transmition of other sexually acquired viruses like the Human Papilloma Virus (HPV). Additionally, he says that nanoparticles could be used to combat bacteria transmitted the same way.

He says that his research team is working on a diagnosis kit that predicts within hours, through blood tests, the resistance of a seropositive person to antiretroviral treatment, results that will help the physician to prescribe the most adequate treatment to patients with HIV.

"Currently, we have these results, but they are preliminary tests and we need to study a lot of seropositive patients to calibrate this kit," he concluded.

Provided by Investigación y Desarrollo

5 /5 (4 votes)
add to favorites email to friend print save as pdf

Related Stories

Synthetic polymer could stop the spread of HIV

Sep 03, 2013

A precisely designed macromolecule that mimics the binding of HIV to immune system cells could be used to stop the virus from physically entering the body, according to a new study led by a materials scientist at Queen Mary ...

New anti-HIV drug target identified

Dec 18, 2013

University of Minnesota researchers have discovered a first-of-its-kind series of compounds possessing anti-human immunodeficiency virus (HIV) activity. The compounds present a new target for potential HIV drug development ...

Nanoparticles loaded with bee venom kill HIV

Mar 08, 2013

(Medical Xpress)—Nanoparticles carrying a toxin found in bee venom can destroy human immunodeficiency virus (HIV) while leaving surrounding cells unharmed, researchers at Washington University School of ...

Recommended for you

The genetics of coping with HIV

19 hours ago

We respond to infections in two fundamental ways. One, which has been the subject of intensive research over the years, is "resistance," where the body attacks the invading pathogen and reduces its numbers. Another, which ...

Long acting HIV drugs to be developed

Sep 11, 2014

HIV drugs which only need to be taken once a month are to be developed at the University of Liverpool in a bid to overcome the problem of 'pill fatigue'.

Puerto Rico partners on US HIV vaccine project

Sep 10, 2014

Puerto Rico's governor says the island's largest public university is partnering with federal agencies to oversee a U.S.-funded project aimed at trying to develop a prophylactic vaccine for the HIV virus that causes AIDS.

User comments